In people, MCH is an independent predictor of iron deficiency, length of hospital stay of people with acute pancreatitis, and premature discontinuation of antiplatelet therapy in people receiving cardiovascular stents indicating this hematologic parameter provides additional information to the more traditionally utilized hemoglobin and MCV (28–30). This evidence concerns the gene PMCH and acute pancreatitis.